Dr. Joseph Connors, Clinical Professor Emeritus in the Department of Medicine at UBC, was appointed to the Order of Canada “for his contributions to the study and treatment of lymphoid cancers, and for his role in the advancement of lymphoma care in Canada.” This month, he was also named on Clarivate’s Highly Cited Researchers 2020 list. Find out which other Vancouver researchers received grants, awards, fellowships and scholarships in December 2020!
Read More
TRIUMF has announced a new research partnership with Ontario-based Fusion Pharmaceuticals to expand production and availability of actinium-225, a valuable but scarce radioisotope with tremendous promise as a cancer treatment. The partnership aims to increase availability of cyclotron-produced actinium-225, bolster the development pipeline from lab bench to bedside, and strengthen Canada’s role as a world leader in isotope production and research. Capitalizing on…
Read More
The host environment in which infection occurs plays a crucial role in the interaction between Pseudomonas aeruginosa and antibiotic treatments. To make up for the lack of new antibiotics, alternative approaches, such as combination therapy and discovery of novel activity of known antibiotics in the host environment, are vital for treatment of pathogens such as P. aeruginosa. This research demonstrates how in vitro conditions…
Read More
In its 20th year, the Canada Research Chairs Program continues to provide opportunities for researchers to excel in their fields, and build teams of experts at Canadian institutions. In winter 2020, the second of two cycles of funding to be announced this year, the Government of Canada is investing approximately $195 million towards 260 new and renewed Chairs at 47 institutions across…
Read More
When the COVID-19 pandemic hit British Columbia at the beginning of 2020, its effect on BC’s health research system and workforce was undeniable. The pandemic has been a watershed moment for science, upending universities, altering scholarly communication, and raising questions about the long-term impacts on research funding and priorities.[1] It has also highlighted the critical role of health research in…
Read More
This year marks the 20th anniversary of the founding of Genome BC, the genomics research organization that has put British Columbia at the forefront of global life sciences innovation and the efforts to positively impact life, every day. “Leadership in health research improves the lives of British Columbians, ensures the safety and sustainability of our health-care system,” said Health Minister Adrian…
Read More
Hematopoietic clones with leukemogenic mutations arise in healthy people as they age, but progression to acute myeloid leukemia (AML) is rare. Recent evidence suggests that the microenvironment may play an important role in modulating human AML population dynamics. To investigate this concept further, we examined the combined and separate effects of an oncogene (c-MYC) and exposure to interleukin-3 (IL-3), granulocyte-macrophage…
Read More
Share prices of AbCellera Biologics Inc. (Nasdaq:ABCL) nearly tripled over the course of their first day of trading following a monster initial public offering for the Vancouver biotech firm. The West Coast company saw share prices close Friday (December 11) at US$58.90, bringing its market value to more than US$15.7 billion. Shares debuted at US$20 but trading was halted from…
Read More